טוען...
Omalizumab improves forced expiratory volume in 1 second in patients with severe asthma
INTRODUCTION: Asthma is a multiphenotypic disease, and therapeutic managenment in patients with severe asthma is particulary difficult, with conventional treatment of severe asthma showing poor efficacy. AIM: To analyse forced expiratory volume in 1 s (FEV(1)) following the adminstration of omalizum...
שמור ב:
| הוצא לאור ב: | Postepy Dermatol Alergol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Termedia Publishing House
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6232554/ https://ncbi.nlm.nih.gov/pubmed/30429708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2018.77241 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|